Gyorgy Lajtai
Founder and CEO
LynxKite Bio
Singapore, Singapore
9 profile visits
We founded LynxKite to accelerate early-stage discovery through screening pipelines married with graph simulation and scalable GPU-orchestration in both code/visual pipelines. Our first partnerships are in computational longevity.
My organisation
LynxKite is a drug discovery software company focused on accelerating early-stage therapeutic discovery through systems biology, knowledge graphs, graph neural networks, virtual screening, and GPU-scale workflow orchestration. The platform is designed to connect biological networks, multimodal biomedical data, and AI-driven modeling into reproducible discovery pipelines that help researchers move from target and mechanism exploration to candidate prioritization and GPU orchestration. Our first EUREKA collaboration develops longevity drugs for sarcopenia via the MAS receptor with Biophytis, as presented during NVIDIA GTC along with our GPU cloud partner Nebius.